	Chronic obstructive pulmonary disease (COPD)
Model
Spain
Bronchodilators
Cost effectiveness
Quality-adjusted life year (QALY)
	severe
costs
effectiveness
patients
clinical trials
model
disease states
values
tiotropium
salmeterol
life years
Scenarios The first year
QALY
highest
year cost effectiveness
bronchodilators
probabilities
scenario
treatment
perspective
trials
preferred option
year
conservative
Spanish National Health System
chronic obstructive pulmonary disease
COPD severity stages
Spanish healthcare utilisation
decision analytical model
ipratropium
general practitioner
scenario analyses
Analyses
COPD
Spanish study
disease severity
net benefit
CE-planes
ipratropium group
months
data
utilities
similar decline
considerations
economic evaluations
difference
Figure

